Since I was already comfortable with multiple daily injections from other peptide protocols, I wanted to see if splitting the dose made a noticeable difference
This democratization of GLP-1 therapy has sustained demand growth and positioned compounded GLP-1 as a mainstream weight loss option rather than a specialty or exclusive treatment
It covers three agents: liraglutide, semaglutide, and tirzepatide
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
In other studies, particularly the SELECT trial we talked about earlier, with cardiovascular disease in elderly individuals, particularly elderly women, we saw an increase in osteoporosis and fractures
4 reviewing themes
&srotate=0)
